44 related articles for article (PubMed ID: 19567816)
1. Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Hernlund E; Hjerpe E; Avall-Lundqvist E; Shoshan M
Mol Cancer Ther; 2009 Jul; 8(7):1916-23. PubMed ID: 19567816
[TBL] [Abstract][Full Text] [Related]
2. Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer.
Egawa-Takata T; Endo H; Fujita M; Ueda Y; Miyatake T; Okuyama H; Yoshino K; Kamiura S; Enomoto T; Kimura T; Inoue M
Cancer Sci; 2010 Oct; 101(10):2171-8. PubMed ID: 20678156
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells.
Tan Y; Li J; Zhao G; Huang KC; Cardenas H; Wang Y; Matei D; Cheng JX
Nat Commun; 2022 Aug; 13(1):4554. PubMed ID: 35931676
[TBL] [Abstract][Full Text] [Related]
4. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
Ihrlund LS; Hernlund E; Khan O; Shoshan MC
Mol Oncol; 2008 Jun; 2(1):94-101. PubMed ID: 19383331
[TBL] [Abstract][Full Text] [Related]
5. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Issaq SH; Teicher BA; Monks A
Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.
Xintaropoulou C; Ward C; Wise A; Marston H; Turnbull A; Langdon SP
Oncotarget; 2015 Sep; 6(28):25677-95. PubMed ID: 26259240
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Philips KB; Kurtoglu M; Leung HJ; Liu H; Gao N; Lehrman MA; Murray TG; Lampidis TJ
Cancer Chemother Pharmacol; 2014 Feb; 73(2):349-61. PubMed ID: 24292700
[TBL] [Abstract][Full Text] [Related]
8. Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma.
Creaney J; Dick IM; Yeoman D; Wong S; Robinson BW
PLoS One; 2011; 6(10):e26515. PubMed ID: 22022619
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted nano-assemblies for energy-blocking cocktail therapy in cancer.
Chen M; Liu Y; Li Y; Liu X
Acta Biomater; 2024 Jun; ():. PubMed ID: 38908417
[TBL] [Abstract][Full Text] [Related]
10. "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.
Wilczyński JR; Wilczyński M; Paradowska E
Front Oncol; 2023; 13():1201497. PubMed ID: 37448521
[TBL] [Abstract][Full Text] [Related]
11. Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis.
Kim MS; Gernapudi R; Cedeño YC; Polster BM; Martinez R; Shapiro P; Kesari S; Nurmemmedov E; Passaniti A
Oncotarget; 2020 Oct; 11(43):3863-3885. PubMed ID: 33196708
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
Khan T; He Y; Kryza T; Harrington BS; Gunter JH; Sullivan MA; Cuda T; Rogers R; Davies CM; Broomfield A; Gough M; Wu AC; McGann T; Weroha SJ; Haluska P; Forbes JM; Armes JE; Barry SC; Coward JI; Jagasia N; Chetty N; Snell CE; Lourie R; Perrin LC; Hooper JD
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260077
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism.
Yu W; Chen Y; Dubrulle J; Stossi F; Putluri V; Sreekumar A; Putluri N; Baluya D; Lai SY; Sandulache VC
Sci Rep; 2018 Mar; 8(1):4306. PubMed ID: 29523854
[TBL] [Abstract][Full Text] [Related]
14. Metabolic interrogation as a tool to optimize chemotherapeutic regimens.
Sandulache VC; Chen Y; Feng L; William WN; Skinner HD; Myers JN; Meyn RE; Li J; Mijiti A; Bankson JA; Fuller CD; Konopleva MY; Lai SY
Oncotarget; 2017 Mar; 8(11):18154-18165. PubMed ID: 28184025
[TBL] [Abstract][Full Text] [Related]
15. Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.
Song K; Li M; Xu X; Xuan LI; Huang G; Liu Q
Oncol Lett; 2016 Jul; 12(1):334-342. PubMed ID: 27347147
[TBL] [Abstract][Full Text] [Related]
16. Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression.
Gong H; Wu TT; Clarke EM
BMC Syst Biol; 2014; 8 Suppl 1(Suppl 1):S3. PubMed ID: 24565114
[TBL] [Abstract][Full Text] [Related]
17. In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.
Formentini L; Pereira MP; Sánchez-Cenizo L; Santacatterina F; Lucas JJ; Navarro C; Martínez-Serrano A; Cuezva JM
EMBO J; 2014 Apr; 33(7):762-78. PubMed ID: 24521670
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistance.
Xiao X; Yang J; Li R; Liu S; Xu Y; Zheng W; Yi Y; Luo Y; Gong F; Peng H; Pei M; Deng M; Zhang G
PLoS One; 2013; 8(12):e83610. PubMed ID: 24391795
[TBL] [Abstract][Full Text] [Related]
19. Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.
Hjerpe E; Egyhazi Brage S; Carlson J; Frostvik Stolt M; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
BMC Clin Pathol; 2013 Nov; 13(1):30. PubMed ID: 24252137
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
